RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994

Content Provider: World eBook Library

Please Log-in to view this content

If you are not a registered user, please register first and then use the e-mail id and password to log-in.